Jayasree K. Iyer comments on what GSK’s new patent policy means for the developing world

Nature

In the article, Jayasree K. Iyer comments on the effect of GSK’s┬ámove on other companies with bigger cancer portfolios.

Follow us and engage with us on LinkedIn and Twitter.